Eris Lifesciences P/B Ratio
ERIS • Price-to-Book ratio analysis and book value breakdown
Current P/B Ratio
6.84
High Valuation
Very High - Significant premium, high growth expectations or speculative
Current Valuation Metrics
P/B Ratio
6.84
Current Price
₹1534.40
Book Value/Share
₹2337.14
Exchange
NSE
Book Value Breakdown (2025)
Balance Sheet Components
Total Equity
₹3,272 Cr
Share Capital
₹14 Cr
Reserves & Surplus
₹2,841 Cr
Outstanding Shares
14,000,000
Book Value per Share
₹2337.14
Valuation Signal
Signal
Overvalued
Historical Avg
0.59
Historical Range
0.47 - 0.68
Percentile
100.0%
Sector Context
Sector Average
-0.1
Sector Median
0.66
Sector Rank
#11 of 50
Sector Percentile
22.0%
Key P/B Ratio Insights for Eris Lifesciences
- Stock appears overvalued with PB of 6.84, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 1055.4% above historical average
- Trading at premium to sector average PB of -0.1
View the current stock price of Eris Lifesciences for more insights.
P/B Ratio Historical Trend for Eris Lifesciences
Historical P/B ratio trend based on balance sheet data. P/B below 1.0 may indicate undervaluation, while higher ratios suggest growth expectations or asset-light business models.
Related Pages for Eris Lifesciences
Additional stock information and data for ERIS
Historical P/B Ratio Data
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 0.64 | ₹2337.14 | ₹1505.60 | ₹3,272 | Low |
| 2024 | 0.6 | ₹2301.43 | ₹1373.70 | ₹3,222 | Low |
| 2023 | 0.57 | ₹1586.43 | ₹910.00 | ₹2,221 | Low |
| 2022 | 0.47 | ₹1362.86 | ₹647.25 | ₹1,908 | Low |
| 2021 | 0.68 | ₹1125.71 | ₹760.05 | ₹1,576 | Low |
Sector P/B Ratio Comparison
Comparing Eris Lifesciences with other companies in Healthcare sector
Sector Average
-0.1
Sector Median
0.66
Lowest P/B
-12.97
Highest P/B
1.2
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sun Pharma Advanced Rese… | SPARC | -12.97 | ₹4,391 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.47 | ₹95 | Low |
| Parmax Pharma | PARMAX | -2.15 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.96 | ₹154 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |
| Murae Organisor | MURAE | 0.26 | ₹55 | Low |